$40.46
0.61%
NYSE, Apr 21, 08:16 pm CET
ISIN
NL0012169213
Symbol
QGEN

QIAGEN NV Stock price

$40.71
+0.89 2.24% 1M
-3.20 7.29% 6M
-5.09 11.12% YTD
+0.36 0.89% 1Y
-8.57 17.38% 3Y
-2.30 5.35% 5Y
+13.02 47.00% 10Y
NYSE, Closing price Thu, Apr 17 2025
-0.73 1.76%
ISIN
NL0012169213
Symbol
QGEN
Sector

Key metrics

Market capitalization $8.80b
Enterprise Value $9.16b
P/E (TTM) P/E ratio 109.58
EV/FCF (TTM) EV/FCF 18.08
EV/Sales (TTM) EV/Sales 4.63
P/S ratio (TTM) P/S ratio 4.45
P/B ratio (TTM) P/B ratio 2.47
Dividend yield 3.33%
Last dividend (FY24) $1.36
Revenue growth (TTM) Revenue growth 0.66%
Revenue (TTM) Revenue $1.98b
EBIT (operating result TTM) EBIT $494.96m
Free Cash Flow (TTM) Free Cash Flow $506.38m
Cash position $1.15b
EPS (TTM) EPS $0.37
P/E forward 20.23
P/S forward 4.34
EV/Sales forward 4.51
Short interest 2.78%
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

12x Buy
52%
11x Hold
48%

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

Buy
52%
Hold
48%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,978 1,978
1% 1%
100%
- Direct Costs 725 725
2% 2%
37%
1,253 1,253
2% 2%
63%
- Selling and Administrative Expenses 361 361
3% 3%
18%
- Research and Development Expense 193 193
3% 3%
10%
698 698
7% 7%
35%
- Depreciation and Amortization 203 203
1% 1%
10%
EBIT (Operating Income) EBIT 495 495
11% 11%
25%
Net Profit 84 84
76% 76%
4%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
Business Wire
7 days ago
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its portfolio for automated sample preparation. These systems are designed to deliver new levels of efficiency and sustainability for laboratories worldw...
Neutral
Business Wire
13 days ago
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2025. Press release date / time: Wednesday, May 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time. Conference call date / time: Thursday, May 8, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time. ...
Neutral
Business Wire
15 days ago
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary Q1 2025 results that exceeded its outlook for both net sales and adjusted earnings per share (EPS), reflecting strong performances across many growth drivers. Net sales grew approximately 5% (+7% at constant exchange rates, CER) to about $483 million in Q1 2025, surpassing th...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Employees 5,765
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today